Literature DB >> 24198421

A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.

Rebecca L Brocato1, Christopher D Hammerbeck, Todd M Bell, Jay B Wells, Laurie A Queen, Jay W Hooper.   

Abstract

Sin Nombre virus (SNV) is a rodent-borne hantavirus that causes hantavirus pulmonary syndrome (HPS) predominantly in North America. SNV infection of immunocompetent hamsters results in an asymptomatic infection; the only lethal disease model for a pathogenic hantavirus is Andes virus (ANDV) infection of Syrian hamsters. Efforts to create a lethal SNV disease model in hamsters by repeatedly passaging virus through the hamster have demonstrated increased dissemination of the virus but no signs of disease. In this study, we demonstrate that immunosuppression of hamsters through the administration of a combination of dexamethasone and cyclophosphamide, followed by infection with SNV, results in a vascular leak syndrome that accurately mimics both HPS disease in humans and ANDV infection of hamsters. Immunosuppressed hamsters infected with SNV have a mean number of days to death of 13 and display clinical signs associated with HPS, including pulmonary edema. Viral antigen was widely detectable throughout the pulmonary endothelium. Histologic analysis of lung sections showed marked inflammation and edema within the alveolar septa of SNV-infected hamsters, results which are similar to what is exhibited by hamsters infected with ANDV. Importantly, SNV-specific neutralizing polyclonal antibody administered 5 days after SNV infection conferred significant protection against disease. This experiment not only demonstrated that the disease was caused by SNV, it also demonstrated the utility of this animal model for testing candidate medical countermeasures. This is the first report of lethal disease caused by SNV in an adult small-animal model.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24198421      PMCID: PMC3911685          DOI: 10.1128/JVI.02906-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes.

Authors:  L C Meagher; J M Cousin; J R Seckl; C Haslett
Journal:  J Immunol       Date:  1996-06-01       Impact factor: 5.422

2.  Effects of immunosuppression on West Nile virus infection in hamsters.

Authors:  Rosa Mateo; Shu-Yuan Xiao; Hilda Guzman; Hao Lei; Amelia P A Travassos Da Rosa; Robert B Tesh
Journal:  Am J Trop Med Hyg       Date:  2006-08       Impact factor: 2.345

3.  Update: outbreak of hantavirus infection--southwestern United States, 1993.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1993-06-18       Impact factor: 17.586

4.  Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity.

Authors:  Yuko Ikezawa; Masatoshi Nakazawa; Chizuru Tamura; Kazuo Takahashi; Mutsuhiko Minami; Zenro Ikezawa
Journal:  J Dermatol Sci       Date:  2005-08       Impact factor: 4.563

5.  Effects of glucocorticoids on apoptosis of infiltrated eosinophils and neutrophils in rats.

Authors:  T Nittoh; H Fujimori; Y Kozumi; K Ishihara; S Mue; K Ohuchi
Journal:  Eur J Pharmacol       Date:  1998-07-31       Impact factor: 4.432

Review 6.  Vaccines for hantaviruses.

Authors:  Connie Schmaljohn
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

7.  Immunosuppression-induced susceptibility of inbred hamsters (Mesocricetus auratus) to lethal-disease by lymphocytic choriomeningitis virus infection.

Authors:  E V Genovesi; C J Peters
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

8.  Granulocyte colony-stimulating factor delays neutrophil apoptosis by inhibition of calpains upstream of caspase-3.

Authors:  Bram J van Raam; Agata Drewniak; Vincent Groenewold; Timo K van den Berg; Taco W Kuijpers
Journal:  Blood       Date:  2008-06-04       Impact factor: 22.113

9.  A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).

Authors:  Jay W Hooper; Matthew Josleyn; John Ballantyne; Rebecca Brocato
Journal:  Vaccine       Date:  2013-07-24       Impact factor: 3.641

10.  Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms.

Authors:  Elizabeth M King; Joanna E Chivers; Christopher F Rider; Anne Minnich; Mark A Giembycz; Robert Newton
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more
  24 in total

Review 1.  Hemorrhagic fever of bunyavirus etiology: disease models and progress towards new therapies.

Authors:  Brian B Gowen; Brady T Hickerson
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 3.422

2.  Association of Single-Nucleotide Polymorphisms in IL28B, but Not TNF-α, With Severity of Disease Caused by Andes Virus.

Authors:  Jenniffer Angulo; Karla Pino; Natalia Echeverría-Chagas; Claudia Marco; Constanza Martínez-Valdebenito; Héctor Galeno; Eliecer Villagra; Lilian Vera; Natalia Lagos; Natalia Becerra; Judith Mora; Andrea Bermúdez; Marcela Cárcamo; Janepsy Díaz; Juan Francisco Miquel; Marcela Ferrés; Marcelo López-Lastra
Journal:  Clin Infect Dis       Date:  2015-09-22       Impact factor: 9.079

3.  Lethal disease in infant and juvenile Syrian hamsters experimentally infected with Imjin virus, a newfound crocidurine shrew-borne hantavirus.

Authors:  Se Hun Gu; Young-Sik Kim; Luck Ju Baek; Takeshi Kurata; Richard Yanagihara; Jin-Won Song
Journal:  Infect Genet Evol       Date:  2015-09-12       Impact factor: 3.342

4.  Neutrophil depletion suppresses pulmonary vascular hyperpermeability and occurrence of pulmonary edema caused by hantavirus infection in C.B-17 SCID mice.

Authors:  Takaaki Koma; Kumiko Yoshimatsu; Noriyo Nagata; Yuko Sato; Kenta Shimizu; Shumpei P Yasuda; Takako Amada; Sanae Nishio; Hideki Hasegawa; Jiro Arikawa
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

Review 5.  Hantavirus infection: a global zoonotic challenge.

Authors:  Hong Jiang; Xuyang Zheng; Limei Wang; Hong Du; Pingzhong Wang; Xuefan Bai
Journal:  Virol Sin       Date:  2017-01-23       Impact factor: 4.327

6.  Hantavirus entry: Perspectives and recent advances.

Authors:  Eva Mittler; Maria Eugenia Dieterle; Lara M Kleinfelter; Megan M Slough; Kartik Chandran; Rohit K Jangra
Journal:  Adv Virus Res       Date:  2019-08-07       Impact factor: 9.937

Review 7.  Innate Immunity to Orthohantaviruses: Could Divergent Immune Interactions Explain Host-specific Disease Outcomes?

Authors:  Alison M Kell
Journal:  J Mol Biol       Date:  2021-09-04       Impact factor: 5.469

8.  Differential pathogenesis between Andes virus strains CHI-7913 and Chile-9717869in Syrian Hamsters.

Authors:  Bryce M Warner; Angela Sloan; Yvon Deschambault; Sebastian Dowhanik; Kevin Tierney; Jonathan Audet; Guodong Liu; Derek R Stein; Oliver Lung; Cody Buchanan; Patrycja Sroga; Bryan D Griffin; Vinayakumar Siragam; Kathy L Frost; Stephanie Booth; Logan Banadyga; Greg Saturday; Dana Scott; Darwyn Kobasa; David Safronetz
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

9.  Binding of the Andes Virus Nucleocapsid Protein to RhoGDI Induces the Release and Activation of the Permeability Factor RhoA.

Authors:  Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

10.  Antiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus.

Authors:  Jennifer Mayor; Olivier Engler; Sylvia Rothenberger
Journal:  Microorganisms       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.